Abg-wtt Global Life Science Capital Partners Gp Ltd 13F annual report
Abg-wtt Global Life Science Capital Partners Gp Ltd is an investment fund managing more than $30 billion ran by Fan Yu. There are currently 3 companies in Yu’s portfolio. The largest investments include Cg Oncology Inc and Rapid Micro Biosystems Inc, together worth $29.6 billion.
$30 billion Assets Under Management (AUM)
As of 7th August 2024, Abg-wtt Global Life Science Capital Partners Gp Ltd’s top holding is 915,501 shares of Cg Oncology Inc currently worth over $28.9 billion and making up 96.4% of the portfolio value.
In addition, the fund holds 1,038,296 shares of Rapid Micro Biosystems Inc worth $685 million.
The third-largest holding is Pulmonx Corp worth $382 million.
Currently, Abg-wtt Global Life Science Capital Partners Gp Ltd's portfolio is worth at least $30 billion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
Careers at Abg-wtt Global Life Science Capital Partners Gp Ltd
The Abg-wtt Global Life Science Capital Partners Gp Ltd office and employees reside in Hong Kong, Hong Kong. According to the last 13-F report filed with the SEC, Fan Yu serves as the Director at Abg-wtt Global Life Science Capital Partners Gp Ltd.
One of the smallest hedge funds
The two most similar investment funds to Abg-wtt Global Life Science Capital Partners Gp Ltd are Aberdeen Asset Management Plc/uk and Csu Producer Resources. They manage $30 billion and $30 billion respectively.
Fan Yu investment strategy
Abg-wtt Global Life Science Capital Partners Gp Ltd’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 1.3% of
the total portfolio value.
The fund focuses on investments in the United States as
33.3% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $256 million.
The complete list of Abg-wtt Global Life Science Capital Partners Gp Ltd trades based on 13F SEC filings
These positions were updated on August 14th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Cg Oncology Inc |
No change
915,501
|
$28,902,367,000 | 96.44% |
| Rapid Micro Biosystems Inc |
No change
1,038,296
|
$685,275,000 | 2.29% |
| Pulmonx Corp |
No change
60,204
|
$381,693,000 | 1.27% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||
Hedge funds similar to Abg-wtt Global Life Science Capital Partners Gp Ltd
- Certares Management
- Envoi
- Systematic Portfolios
- Lord, Abbett & Co
- Blackrock Japan Co. Ltd
- Csu Producer Resources
- Aberdeen Asset Management Plc/uk
- Chubb Ltd
- Arboretum Ventures
- Standard Life Investments Ltd
- Scf Partners
- Benefit Street Partners
- Appleton Group
- Ursa Fund Management